Why Do We Keep Ignoring the World’s Leading Killer?

Why Do We Keep Ignoring the World’s Leading Killer?
share Share

High blood pressure is the world’s leading killer. It will kill more people than COVID-19, and, in usual circumstances, more than all infectious diseases combined. However, very little coverage or importance is given to this deadly condition, even though high blood pressure is a preventable risk factor. It can be prevented by reducing dietary sodium. It can also be treated quite effectively with drugs.


Nevertheless, it continues to kill numerous people worldwide. Studies show that less than 1 in 7 people with high blood pressure have this problem in control. This means that most people with hypertension globally do not have it under control, even though it is a treatable and preventable disorder.


Studies also show that for every 20-point increase in systolic blood pressure, the rate of death from cardiovascular disease doubles. Findings from the SPRINT study showed that intensive treatment of blood pressure to reach optimum blood pressure goals is safe and can play an important role in preventing heart attacks, strokes and deaths. Despite the common perception that blood pressure should not be too low, clinical evidence now suggests that lower blood pressure is better and that a lower blood pressure goal could save many lives.


Clinical data shows that people treated with a goal of 120/80 had a lower rate of death compared to people treated with the usual target of 140/90. It is also important to note that drug interventions are not the only approach that could be used in hypertensive patients. Reducing sodium, increasing physical activity, eating a healthier diet and reducing air pollution can all contribute to reducing blood pressure.


It is time to take this condition seriously. Lowering blood pressure could save millions of lives if only more awareness, more action and more preventable strategies were adopted when managing patients with blood pressure.


Source: NEJM, Circulation

Image Credit: iStock


«« The Dilemma of Using Location-Based Terms for COVID-19 Variants

From an Epidemic of Fear to an Epidemic of Explanations »»


SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, et al. (2021) Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med., 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281. 

Published on : Tue, 1 Jun 2021

Related Articles

With the recent surge of COVID-19 cases in India, talks of the “Indian variant” have been circulating over social media. However,... Read more

According to latest findings, decreases in life expectancy during 2020 were much larger in the United States than in other high... Read more

Findings from a new study published in PLOS ONE show that patients taking statins had a 41% lower risk of in-hospital death from... Read more

high blood pressure, preventable deaths, hypertension., COVID-19 Why Do We Keep Ignoring the World’s Leading Killer?

No comment

Please login to leave a comment...

Highlighted Products